Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Yuxin Shen

Matched on ORCID iD 0009-0004-1742-0797; OpenAlex author ID A5101311753. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 4 papers · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 11

  1. Dietary inflammatory potential and pancreatic cancer risk: a systematic review and dose-response meta-analysis First author DOI 10.21203/rs.3.rs-4761786/v1↗
  2. Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles. Co-author DOI 10.1111/cas.14486↗
  3. Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Cons… Co-author DOI 10.3389/fonc.2021.729490↗
  4. Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of m… Co-author DOI 10.20892/j.issn.2095-3941.2019.0101↗
  5. Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Tar… Co-author DOI 10.1016/j.ijrobp.2019.01.075↗
  6. Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1002/cam4.1553↗
  7. Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD scor… Co-author DOI 10.1016/j.radonc.2018.08.012↗
  8. Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matc… Co-author DOI 10.2147/cmar.s163655↗
  9. Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pa… Co-author DOI 10.2147/cmar.s166713↗
  10. Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer. Co-author DOI 10.1002/cam4.1164↗
  11. Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally adva… Co-author DOI 10.1136/bmjopen-2016-013220↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yangsen Cao · 10 shared papers, 2016–2021 · strength 0.88
  2. Shuiwang Qing · 10 shared papers, 2016–2021 · strength 0.88
  3. Xiaofei Zhu · 10 shared papers, 2016–2021 · strength 0.88
  4. Huojun Zhang · 10 shared papers, 2016–2021 · strength 0.88
  5. Mingxia Chen · 1 shared paper, 2024 · strength 0.28
  6. Jiang Li · 1 shared paper, 2024 · strength 0.28
  7. Yusheng Ye · 1 shared paper, 2021 · strength 0.13
  8. Lingong Jiang · 1 shared paper, 2021 · strength 0.13
  9. Di Chen · 1 shared paper, 2020 · strength 0.11
  10. Wenyu Liu · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.